Use of fibrin sealant in vein anastomosis in renal transplantation and its effect in preventing blood loss and postoperative peri-graft collection.

IF 1.8 4区 医学 Q3 UROLOGY & NEPHROLOGY International Urology and Nephrology Pub Date : 2024-10-26 DOI:10.1007/s11255-024-04247-7
Raj Man Dongol, Mrinal Pahwa, Subarna Adhikari, Bindu Adhikari
{"title":"Use of fibrin sealant in vein anastomosis in renal transplantation and its effect in preventing blood loss and postoperative peri-graft collection.","authors":"Raj Man Dongol, Mrinal Pahwa, Subarna Adhikari, Bindu Adhikari","doi":"10.1007/s11255-024-04247-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study is to assess efficacy of fibrin sealant in vein anastomosis in renal transplantation in preventing blood loss and postoperative peri-graft collection.</p><p><strong>Methods: </strong>This is a retrospective analytical case-control study of renal transplantations done in a tertiary care center in India in a 1-year period. Fibrin sealant was randomly used in vein anastomosis during the period. All the data were extracted and retrospectively analyzed. Those with fibrin sealant use were the study group and without sealant use were the control group. Primary objective was to assess effectiveness of fibrin sealant in preventing blood loss and postoperative peri-graft collection. Secondary objectives were to evaluate patients' demographic profile, hospital stay and other intraoperative and postoperative characteristics.</p><p><strong>Results: </strong>During the study, 163 patients were enrolled, 82 study group and 81 control group. Warm ischemia, cold ischemia and operative times of study group were 2.57 ± 2.03, 44.23 ± 8.89 and 189.6 ± 51.6 min, respectively, and that of control group were 2.67 ± 2.07, 42.37 ± 8.5 and 178.8 ± 54.6 min, respectively. The mean intraoperative blood loss in study and control groups was 124.83 ± 110.89 and 155 ± 50.27 ml, respectively, and the difference was statistically significant (p .027). The mean peri-graft collection in study group and control group were 72.33 ± 29.18 ml and 134.67 ± 102.84 ml, respectively, but the difference was not statistically significant (p .086). The study also demonstrated that the duration of hospital stays significantly differed between two groups (p < .043).</p><p><strong>Conclusion: </strong>In this study, fibrin sealant has demonstrated both safety and efficacy in effectively managing bleeding, sealing vascular anastomoses, and mitigating peri-graft collection.</p>","PeriodicalId":14454,"journal":{"name":"International Urology and Nephrology","volume":" ","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2024-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Urology and Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11255-024-04247-7","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: This study is to assess efficacy of fibrin sealant in vein anastomosis in renal transplantation in preventing blood loss and postoperative peri-graft collection.

Methods: This is a retrospective analytical case-control study of renal transplantations done in a tertiary care center in India in a 1-year period. Fibrin sealant was randomly used in vein anastomosis during the period. All the data were extracted and retrospectively analyzed. Those with fibrin sealant use were the study group and without sealant use were the control group. Primary objective was to assess effectiveness of fibrin sealant in preventing blood loss and postoperative peri-graft collection. Secondary objectives were to evaluate patients' demographic profile, hospital stay and other intraoperative and postoperative characteristics.

Results: During the study, 163 patients were enrolled, 82 study group and 81 control group. Warm ischemia, cold ischemia and operative times of study group were 2.57 ± 2.03, 44.23 ± 8.89 and 189.6 ± 51.6 min, respectively, and that of control group were 2.67 ± 2.07, 42.37 ± 8.5 and 178.8 ± 54.6 min, respectively. The mean intraoperative blood loss in study and control groups was 124.83 ± 110.89 and 155 ± 50.27 ml, respectively, and the difference was statistically significant (p .027). The mean peri-graft collection in study group and control group were 72.33 ± 29.18 ml and 134.67 ± 102.84 ml, respectively, but the difference was not statistically significant (p .086). The study also demonstrated that the duration of hospital stays significantly differed between two groups (p < .043).

Conclusion: In this study, fibrin sealant has demonstrated both safety and efficacy in effectively managing bleeding, sealing vascular anastomoses, and mitigating peri-graft collection.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在肾移植静脉吻合术中使用纤维蛋白密封剂及其对防止失血和术后移植物周围集血的效果。
目的:本研究旨在评估纤维蛋白密封剂在肾移植静脉吻合术中防止失血和术后移植物周围集血的效果:这是一项回顾性病例对照分析研究,研究对象是印度一家三级医疗中心一年内完成的肾移植手术。在此期间,静脉吻合术中随机使用了纤维蛋白密封剂。研究人员提取了所有数据并进行了回顾性分析。使用纤维蛋白密封剂的为研究组,未使用密封剂的为对照组。首要目标是评估纤维蛋白密封剂在防止失血和术后移植物周围集血方面的效果。次要目标是评估患者的人口统计学特征、住院时间及其他术中和术后特征:研究期间,共招募了 163 名患者,其中研究组 82 人,对照组 81 人。研究组的热缺血时间、冷缺血时间和手术时间分别为(2.57±2.03)分钟、(44.23±8.89)分钟和(189.6±51.6)分钟,对照组的热缺血时间、冷缺血时间和手术时间分别为(2.67±2.07)分钟、(42.37±8.5)分钟和(178.8±54.6)分钟。研究组和对照组的术中平均失血量分别为(124.83 ± 110.89)毫升和(155 ± 50.27)毫升,差异有统计学意义(P .027)。研究组和对照组的平均移植物周围采集量分别为 72.33 ± 29.18 毫升和 134.67 ± 102.84 毫升,但差异无统计学意义(P 086)。研究还表明,两组患者的住院时间有明显差异(P 结论:两组患者的住院时间差异不大:在这项研究中,纤维蛋白密封剂在有效控制出血、密封血管吻合口和减少移植物周围集血方面表现出了安全性和有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
International Urology and Nephrology
International Urology and Nephrology 医学-泌尿学与肾脏学
CiteScore
3.40
自引率
5.00%
发文量
329
审稿时长
1.7 months
期刊介绍: International Urology and Nephrology publishes original papers on a broad range of topics in urology, nephrology and andrology. The journal integrates papers originating from clinical practice.
期刊最新文献
Correction to: Finerenone in type 2 diabetic and albuminuric renal disease patients: three case reports. Crohn's disease-associated IgA nephropathy may prone to better renal outcome. Docetaxel versus androgen receptor signaling inhibitor (ARSI) against chemo-naïve castration-resistant prostate cancer (CRPC): propensity score matched analysis in real world. Analysis of factors influencing the trajectory of fatigue in maintenance haemodialysis patients: a longitudinal study. Prevalence of kidney disease in patients with different types of cancer or hematological malignancies: a cross-sectional study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1